Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) EBITDA

Alert me on EBITDA

Abbott Laboratories's EBITDA for fiscal 2025 was $11.2B, up 11.2% from $10.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $10.8B. Over the past ten years it has ranged from $4.3B (fiscal 2015) to $12.0B (fiscal 2021); the current reading is higher than 82% of that period. Abbott Laboratories ranks 1st of 147 Medical Devices companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $11.2B 11.21%
FY2024 $10.0B 3.31%
FY2023 $9.7B (16.41%)
FY2022 $11.6B (2.79%)
FY2021 $12.0B 37.76%
FY2020 $8.7B 15.08%
FY2019 $7.5B 8.42%
FY2018 $7.0B 26.61%
FY2017 $5.5B 20.97%
FY2016 $4.5B 4.72%

Quarterly newest first

Period EBITDA Change
Jun 2026 $2.8B 28.17%
Mar 2026 $2.1B (29.41%)
Dec 2025 $3.0B 6.85%
Sep 2025 $2.8B 0.67%
42 more quarters

Against its own ten years

Low $4.3B High $12.0B
Ten-year median $8.7B
Current reading's percentile 82

EBITDA against peers

Company EBITDA
ABT Abbott Laboratories $10.8B
MDT Medtronic PLC compare $9.7B
SYK Stryker Corporation compare $6.8B
BSX Boston Scientific Corporation compare $5.6B
PHG Koninklijke Philips N.V. compare $3.4B
GEHC GE HealthCare Technologies Inc. compare $3.3B
STE STERIS plc compare $1.6B
EW Edwards Lifesciences Corporation compare $1.6B
DXCM DexCom, Inc. compare $1.4B

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on ABT